Psoriasis | Arcutis | ARQ-154-204
Pharmaceutical Company/Sponsor:
Arcutis
Code:
ARQ-154-204
Title:
A Phase 2b, 8-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-154 Foam 0.3% Administered QD in Adolescents and Adults With Scalp and Body Psoriasis
Type:
Interventional
Phase:
2
Condition/Disease:
Psoriasis
Intervention(s)/Treatment(s):
Drug: ARQ-154
Status:
Recruiting
Link for Additional Information:
